biorasi Blogs
-
Dermatology Detectives: How The Right Principal Investigator Can Increase Patient Trust And Compliance
5/6/2019
When conducting complex dermatology clinical trials with difficult to treat, rare, or complicated skin conditions, the study’s success or failure can often hinge on the relationship between the PI and patients. Learn what to look for in a dermatology study investigator.
-
How To Minimize Subjectivity In Dermatology – Part 1: Principal Investigators And Clinical Staff
5/3/2019
The success of any clinical trial depends on unbiased data. However, the subjective nature of many dermatology assessments makes unbiased data harder to come by. Inconsistent reports based on subjective findings can skew data, which may obscure the true effects of treatment. In-depth training of investigators and staff helps minimize subjectivity, but even traditional training can fall short. Here are a few solutions.
-
Cosmeceuticals: How To Navigate The Legal And Regulatory Hurdles Of A Growing Market
5/3/2019
Laws and regulations differ greatly between drugs and cosmetics. Drugs must be submitted for FDA approval. Cosmetics are not. Product manufacturers should know what constitutes a legitimately clinically proven cosmeceutical, as well as what the FDA has to say about these cosmetic-drug hybrids.
-
What Is The Skin Microbiome?
5/3/2019
The microbiome refers to the genetic material of all the microbes that live on and inside the human body. Using DNA sequencing, researchers are only beginning to uncover links between the microbiome and a host of diseases, including several types of cancer, autoimmune conditions, inflammatory bowel disease, and Crohn’s disease, among others.
-
What Are The Advantages Of Virtual Trials?
5/2/2019
Cost-savings and patient-centricity are two forces that are combining to push the boundaries of what a clinical trial is and can be. One of the new solutions is the virtual trial, and it carries with it many advantages over a traditional trial. Read more about the advantages of virtual clinical trials.
-
Commonalities Of Rare Diseases
5/2/2019
Along with a fear of a low ROI, pharmaceutical companies have been hesitant to take on rare disease drug development because the indications can be challenging to study. Although each rare disease is unique, some elements of the clinical operations of rare disease trials are consistent across indications. Here are some common challenges experienced during the course of researching rare diseases.
-
The Current Standing Of Research On Stem Cell Therapies For Wound Healing
5/2/2019
Wound healing is a complicated and dynamic process that includes multiple overlapping phases. To control costs and improve outcomes for wound-care patients, researchers are turning to regenerative medicine; specifically, stem cell therapy. Read more about the types of stem cells and how they assist with wound healing.
-
The Future Of Diabetes Treatment
5/1/2019
For those of us who are living with or who have a family member living with type 1 diabetes, we are probably well acquainted with the promises of pancreas transplants, islet stem cell therapy, and other science fiction. But what types of advances can we realistically hope for in the next 5 to 10 years? Or maybe even in the next 2 years?
-
A Deep Dive Into NASH Physiology And Drug Targets
5/1/2019
One of the problems with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) has been a lack of understanding of the basic science. Up until the past few years, the treatment approach outside of changing lifestyle factors (i.e. diet and exercise) has been to repurpose old drugs that were used for metabolic syndrome or type 2 diabetes, since these diseases overlap in many ways. By continuing to study the basic science behind the disease and the drugs designed to treat it so that better, more specific drugs may be developed in the future.
-
How Managers Can Establish Good Working Relationships With Their Internal Team
5/1/2019
A team is only as successful as its leadership, and leading successfully and gracefully is both an art and a science; a title does not make a manager. Following are some of the qualities a strong manager will have.